TY - STD TI - Food, Drug, and Cosmetic Act, 21 U.S.C. 321(h); definition of the term 'device' ('an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part or accessory, which is [2] intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment or prevention of disease, in man or other animals'). ID - ref1 ER - TY - STD TI - 21 CFR §809.3(a); definition of in vitro diagnostic devices ('In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body. These products are devices as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act (the act), and may also be biological products subject to section 351 of the Public Health Service Act.'). FDA (cited 1st April, 2004), [http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm] UR - http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm ID - ref2 ER - TY - CHAP PY - 2004 DA - 2004// BT - FDA White Paper: 'Innovation or stagnation, challenge and opportunity on the critical path to new medical products ID - ref3 ER - TY - STD TI - 'Pharmacogenomics in drug development and regulatory decision making' -- Workshop 3: 'Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines', 11-13th April, 2005, Bethesda, MD. ID - ref4 ER - TY - CHAP PY - 2004 DA - 2004// BT - 'Co-development of drug, biological and device products', 29th July, 2004, Arlington, VA ID - ref5 ER - TY - STD TI - 'Drug metabolizing enzymes and pharmacogenomics' -- a joint FDA/Johns Hopkins University/PhRMA educational workshop, 13-14th September, 2004, Rockville, MD. ID - ref6 ER - TY - CHAP PY - 2005 DA - 2005// BT - Guidance for industry: Pharmacogenomic data submissions ID - ref7 ER - TY - CHAP PY - 2003 DA - 2003// BT - 'Multiplex tests for heritable DNA markers, mutations and expression patterns: Draft guidance for industry and FDA reviewers', March ID - ref8 ER - TY - CHAP PY - 2005 DA - 2005// BT - FDA White Paper: 'Drug-device co-development concept paper (draft) April' ID - ref9 ER - TY - STD TI - 'Microarrays in transcriptional profiling' -- a joint FDA/Johns Hopkins University/PhRMA workshop, 20-21st July, 2005, Rockville, MD. ID - ref10 ER - TY - JOUR AU - Dave, S. S. AU - Wright, G. AU - Tan, B. PY - 2004 DA - 2004// TI - Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041869 DO - 10.1056/NEJMoa041869 ID - Dave2004 ER - TY - JOUR AU - Staudt, L. M. PY - 2003 DA - 2003// TI - Molecular diagnosis of the hematologic cancers JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMra020067 DO - 10.1056/NEJMra020067 ID - Staudt2003 ER - TY - JOUR AU - Shi, L. AU - Tong, W. AU - Goodsaid, F. PY - 2004 DA - 2004// TI - QA/QC: Challenges and pitfalls facing the microarray community and regulatory agencies JO - Expert Rev Mol Diagn VL - 4 UR - https://doi.org/10.1586/14737159.4.6.761 DO - 10.1586/14737159.4.6.761 ID - Shi2004 ER - TY - JOUR AU - Bakay, M. AU - Chen, Y. W. AU - Borup, R. PY - 2002 DA - 2002// TI - Sources of variability and effect of experimental approach on expression profiling data interpretation JO - BMC Bioinformatics [Internet] VL - 3 UR - https://doi.org/10.1186/1471-2105-3-4 DO - 10.1186/1471-2105-3-4 ID - Bakay2002 ER - TY - JOUR AU - Bammler, T. AU - Beyer, R. P. AU - Bhattacharya, S. PY - 2005 DA - 2005// TI - Standardizing global gene expression analysis between laboratories and across platforms JO - Nat Methods VL - 2 UR - https://doi.org/10.1038/nmeth0605-477a DO - 10.1038/nmeth0605-477a ID - Bammler2005 ER - TY - JOUR AU - Irizarry, R. A. AU - Warren, D. AU - Spencer, F. PY - 2005 DA - 2005// TI - Multiplelaboratory comparison of microarray platforms JO - Nat Methods VL - 2 UR - https://doi.org/10.1038/nmeth756 DO - 10.1038/nmeth756 ID - Irizarry2005 ER - TY - JOUR AU - Larkin, J. E. AU - Frank, B. C. AU - Gavras, H. PY - 2005 DA - 2005// TI - Independence and reproducibility across microarray platforms JO - Nat Methods VL - 2 UR - https://doi.org/10.1038/nmeth757 DO - 10.1038/nmeth757 ID - Larkin2005 ER - TY - CHAP AU - Thompson, K. PY - 2005 DA - 2005// BT - 'Interrogation of microarray platform variation and performance with a mixed tissue RNA reference material', at 'Microarrays in transcriptional profiling' -- 'a joint FDA/Johns Hopkins University/PhRMA workshop, 20-21st July, Rockville, MD ID - Thompson2005 ER - TY - JOUR AU - Petersen, D. AU - Chandramouli, G. V. R. AU - Geoghegan, J. PY - 2005 DA - 2005// TI - Three microarray platforms: An analysis of their concordance in profiling gene expression JO - BMC Genomics [Internet] VL - 6 UR - https://doi.org/10.1186/1471-2164-6-63 DO - 10.1186/1471-2164-6-63 ID - Petersen2005 ER - TY - JOUR AU - Shi, L. AU - Tong, W. AU - Fang, H. PY - 2005 DA - 2005// TI - Cross-platform comparability of microarray technology: Intra-platform consistency and appropriate data analysis procedures are essential JO - BMC Bioinformatics [Internet] VL - 6 UR - https://doi.org/10.1186/1471-2105-6-S2-S12 DO - 10.1186/1471-2105-6-S2-S12 ID - Shi2005 ER - TY - JOUR PY - 2004 DA - 2004// TI - Expression profiling-best practices for data generation and interpretation in clinical trials JO - Nat Rev Genetics VL - 5 UR - https://doi.org/10.1038/nrg1297 DO - 10.1038/nrg1297 ID - ref21 ER - TY - JOUR AU - Irizarry, R. A. AU - Hobbs, B. AU - Collin, F. PY - 2004 DA - 2004// TI - Exploration, normalization, and summaries of high density oligonucleotide array probe level data JO - Biostatistics VL - 4 UR - https://doi.org/10.1093/biostatistics/4.2.249 DO - 10.1093/biostatistics/4.2.249 ID - Irizarry2004 ER - TY - CHAP PY - 2005 DA - 2005// BT - 'Diagnostic nucleic acid microarrays', proposed guideline, Document MM12-P ID - ref23 ER - TY - JOUR AU - Carter, S. L. AU - Eklund, A. C. AU - Mecham, B. H. PY - 2005 DA - 2005// TI - Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements JO - BMC Bioinformatics [Internet] VL - 6 UR - https://doi.org/10.1186/1471-2105-6-107 DO - 10.1186/1471-2105-6-107 ID - Carter2005 ER - TY - JOUR AU - Ransohoff, D. F. PY - 2005 DA - 2005// TI - Bias as a threat to the validity of cancer molecular-marker research JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1550 DO - 10.1038/nrc1550 ID - Ransohoff2005 ER - TY - JOUR AU - Ransohoff, D. F. PY - 2004 DA - 2004// TI - Rules of evidence for cancer molecular-marker discovery and validation JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1322 DO - 10.1038/nrc1322 ID - Ransohoff2004 ER - TY - JOUR AU - Simon, R. PY - 2005 DA - 2005// TI - Development and validation of therapeutically relevant multi-gene biomarker classifiers JO - J Natl Cancer Inst VL - 97 UR - https://doi.org/10.1093/jnci/dji168 DO - 10.1093/jnci/dji168 ID - Simon2005 ER - TY - JOUR AU - Simon, R. AU - Radmacher, M. D. AU - Dobbin, K. AU - McShane, L. M. PY - 2003 DA - 2003// TI - Pitfalls in the analysis of DNA microarray data: Class prediction methods JO - J Natl Cancer Inst VL - 95 UR - https://doi.org/10.1093/jnci/95.1.14 DO - 10.1093/jnci/95.1.14 ID - Simon2003 ER - TY - JOUR AU - Simon, R. PY - 2003 DA - 2003// TI - Diagnostic and prognostic prediction using gene expression profiles in high dimensional microarray data JO - Br J Cancer VL - 89 UR - https://doi.org/10.1038/sj.bjc.6601326 DO - 10.1038/sj.bjc.6601326 ID - Simon2003 ER - TY - CHAP AU - Trepicchio, W. L. AU - Essayan, D. AU - Hall, S. T. PY - 2006 DA - 2006// TI - Designing prospective clinical PG trials - Effective use of genomic biomarkers for use in clinical decision-making BT - Pharmacogenomics J ID - Trepicchio2006 ER - TY - JOUR AU - Cutler, D. J. AU - Zwick, M. E. AU - Carrasquillo, M. M. PY - 2001 DA - 2001// TI - Highthroughput variation detection and genotyping using microarrays JO - Genome Res VL - 11 ID - Cutler2001 ER - TY - JOUR AU - Syvanen, A. C. PY - 2001 DA - 2001// TI - Accessing genetic variation: Genotyping single nucleotide polymorphisms JO - Nature Rev Genet VL - 2 UR - https://doi.org/10.1038/35103535 DO - 10.1038/35103535 ID - Syvanen2001 ER - TY - JOUR AU - Warrington, J. A. AU - Shah, N. A. AU - Chen, X. PY - 2002 DA - 2002// TI - New developments in high-throughput resequencing and variation detection using high density microarrays JO - Hum Mutat VL - 19 UR - https://doi.org/10.1002/humu.10075 DO - 10.1002/humu.10075 ID - Warrington2002 ER - TY - JOUR AU - Wang, D. AU - Coscoy, L. AU - Zylberberg, M. PY - 2002 DA - 2002// TI - Microarray-based detection and genotyping of viral pathogens JO - Proc Natl Acad Sci USA VL - 99 UR - https://doi.org/10.1073/pnas.242579699 DO - 10.1073/pnas.242579699 ID - Wang2002 ER - TY - JOUR AU - Volokhov, D. AU - Chizhikov, V. AU - Chumakov, K. AU - Rasooly, A. PY - 2003 DA - 2003// TI - Microarray-based identification of thermophilic Campylobacter jejuni, C. coli, C. lari, and C. upsaliensis JO - J Clin Microbiol VL - 41 UR - https://doi.org/10.1128/JCM.41.9.4071-4080.2003 DO - 10.1128/JCM.41.9.4071-4080.2003 ID - Volokhov2003 ER - TY - JOUR AU - Zwick, M. E. AU - Mcafee, F. AU - Cutler, D. J. PY - 2005 DA - 2005// TI - Microarray-based resequencing of multiple Bacillus anthracis isolates JO - Genome Biol [Internet] VL - 6 UR - https://doi.org/10.1186/gb-2004-6-1-r10 DO - 10.1186/gb-2004-6-1-r10 ID - Zwick2005 ER - TY - JOUR AU - Weinshilboum, R. AU - Wang, L. PY - 2004 DA - 2004// TI - Pharmacogenomics: bench to bedside JO - Nat Rev Drug Discov VL - 3 UR - https://doi.org/10.1038/nrd1497 DO - 10.1038/nrd1497 ID - Weinshilboum2004 ER - TY - JOUR AU - Lesko, L. AU - Woodcock, J. PY - 2004 DA - 2004// TI - Translation of pharmacogenomics and pharmacogenetics: A regulatory perspective JO - Nat Rev Drug Discov VL - 3 UR - https://doi.org/10.1038/nrd1499 DO - 10.1038/nrd1499 ID - Lesko2004 ER - TY - JOUR AU - Harper, C. C. AU - Philip, R. AU - Robinowitz, M. AU - Gutman, S. I. PY - 2005 DA - 2005// TI - FDA perspectives on pharmacogenetic testing JO - Expert Rev Mol Diagn VL - 5 UR - https://doi.org/10.1586/14737159.5.5.643 DO - 10.1586/14737159.5.5.643 ID - Harper2005 ER - TY - JOUR AU - Sebat, J. AU - Lakshmi, B. AU - Troge, J. PY - 2004 DA - 2004// TI - Large-scale copy number polymorphism in the human genome JO - Science VL - 305 UR - https://doi.org/10.1126/science.1098918 DO - 10.1126/science.1098918 ID - Sebat2004 ER - TY - JOUR AU - Iafrate, A. J. AU - Feuk, L. AU - Rivera, M. N. PY - 2004 DA - 2004// TI - Detection of large-scale variation in the human genome JO - Nat Genet VL - 36 UR - https://doi.org/10.1038/ng1416 DO - 10.1038/ng1416 ID - Iafrate2004 ER - TY - JOUR AU - Carter, N. P. PY - 2004 DA - 2004// TI - As normal as normal can be? JO - Nat Genet VL - 36 UR - https://doi.org/10.1038/ng0904-931 DO - 10.1038/ng0904-931 ID - Carter2004 ER - TY - JOUR AU - Pinkel, D. AU - Albertson, D. PY - 2005 DA - 2005// TI - Comparative genomic hybridization JO - Annu Rev Genomics Hum Genet VL - 6 UR - https://doi.org/10.1146/annurev.genom.6.080604.162140 DO - 10.1146/annurev.genom.6.080604.162140 ID - Pinkel2005 ER - TY - JOUR AU - Davies, J. J. AU - Wilson, I. M. AU - Lam, W. L. PY - 2005 DA - 2005// TI - Array CGH technologies and their applications to cancer genomes JO - Chromosome Res VL - 13 UR - https://doi.org/10.1007/s10577-005-2168-x DO - 10.1007/s10577-005-2168-x ID - Davies2005 ER - TY - JOUR AU - Ishkanian, A. S. AU - Malloff, C. A. AU - Watson, S. K. PY - 2004 DA - 2004// TI - A tiling resolution DNA microarray with complete coverage of the human genome JO - Nat Genet VL - 36 UR - https://doi.org/10.1038/ng1307 DO - 10.1038/ng1307 ID - Ishkanian2004 ER - TY - JOUR AU - Barrett, M. T. AU - Scheffer, A. AU - Ben-Dor, A. PY - 2004 DA - 2004// TI - Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA JO - Proc Natl Acad Sci USA VL - 101 UR - https://doi.org/10.1073/pnas.0407979101 DO - 10.1073/pnas.0407979101 ID - Barrett2004 ER - TY - JOUR AU - Dhami, P. AU - Coffey, A. J. AU - Abbs, S. PY - 2005 DA - 2005// TI - Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome JO - Am J Hum Genet VL - 76 UR - https://doi.org/10.1086/429588 DO - 10.1086/429588 ID - Dhami2005 ER - TY - JOUR AU - Hsu, L. AU - Self, S. G. AU - Grove, D. PY - 2005 DA - 2005// TI - Denoising array-based comparative genomic hybridization data using wavelets JO - Biostatistics VL - 6 UR - https://doi.org/10.1093/biostatistics/kxi004 DO - 10.1093/biostatistics/kxi004 ID - Hsu2005 ER - TY - JOUR AU - Mansfield, E. AU - O'Leary, T. J. AU - Gutman, S. I. PY - 2005 DA - 2005// TI - Food and Drug Administration regulation of in vitro diagnostic devices JO - J Mol Diagn VL - 7 UR - https://doi.org/10.1016/S1525-1578(10)60002-5 DO - 10.1016/S1525-1578(10)60002-5 ID - Mansfield2005 ER - TY - CHAP PY - 1998 DA - 1998// BT - New Section 513(f)(2) -- 'Evaluation of automatic Class III designation, guidance for industry and CDRH staff ', February 1998 ID - ref50 ER - TY - CHAP AU - Altaie, S. PY - 2003 DA - 2003// BT - 'The pre-IDE process', presentation at the IVD 510(k) Workshop, 22nd April, 2003, Rockville, MD ID - Altaie2003 ER - TY - CHAP PY - 2005 DA - 2005// BT - Class II special controls guidance document: 'Drug metabolizing enzyme genotyping system -- Guidance for industry and FDA staff' ID - ref52 ER - TY - CHAP PY - 2005 DA - 2005// BT - Instrumentation for clinical multiplex test systems: Class II special controls guidance document -- Guidance for industry and FDA staff ID - ref53 ER - TY - CHAP PY - 2005 DA - 2005// BT - CFTR gene mutation detection systems: Class II special controls guidance document -- Guidance for industry and FDA staff ID - ref54 ER - TY - STD TI - NIST: 2003, [http://www.cstl.nist.gov/biotech/workshops/ERCC2003/] UR - http://www.cstl.nist.gov/biotech/workshops/ERCC2003/ ID - ref55 ER - TY - CHAP PY - 2005 DA - 2005// BT - 'Use of external RNA controls in gene expression assays', proposed guideline, Clinical, Laboratory Standards Institute (CLSI), Document MM16-P ID - ref56 ER - TY - STD TI - Cited 29th August, 2005, [http://www.fda.gov/nctr/science/centers/toxicoinformatics/maqc/] UR - http://www.fda.gov/nctr/science/centers/toxicoinformatics/maqc/ ID - ref57 ER - TY - STD TI - Searle SR, Casella G, McCulloch CE: 1992, Variance Components, Wiley, New York, NY, 501- ID - ref58 ER - TY - CHAP PY - 2004 DA - 2004// BT - 21 CFR §860.7. 'Determination of safety and effectiveness' ID - ref59 ER - TY - CHAP PY - 2005 DA - 2005// BT - Roche AmpliChip Cytochrome P450 Genotyping test and Affymetrix GeneChip Microarray Instrumentation System ID - ref60 ER - TY - CHAP PY - 2005 DA - 2005// BT - Tag-It™ Cystic Fibrosis Kit ID - ref61 ER -